{"product_id":"advanced-healthcare-materials-hardback-9781118773598","title":"Advanced Healthcare Materials (Hardback) 9781118773598","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eAdvanced Healthcare Materials\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eAshutosh Tiwari (Edited by), A Tiwari (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781118773598, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 1 July 2014\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e560 pages\u003cbr\u003e25.9 x 18.5 x 3.3 cm, 1.139 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e“Although they claim in the Preface that this book is written for university students and researchers from diverse backgrounds, I believe having read the majority of the scientific aspects of the work it really expects the reader to have a very thorough knowledge of polymer chemistry at the nanometer level of particle or pore size and suggest this book is aimed at the researchers in the pharmaceutical industry or academics in pharmaceutical chemistry research rather than researchers into biomaterials.”  (\u003ci\u003eScope\u003c\/i\u003e, 1 February 2014)\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eOffers a comprehensive and interdisciplinary view of cutting-edge research on advanced materials for healthcare technology and applications\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAdvanced healthcare materials are attracting strong interest in fundamental as well as applied medical science and technology. This book summarizes the current state of knowledge in the field of advanced materials for functional therapeutics, point-of-care diagnostics, translational materials, and up-and-coming bioengineering devices. \u003ci\u003eAdvanced Healthcare Materials\u003c\/i\u003e highlights the key features that enable the design of stimuli-responsive smart nanoparticles, novel biomaterials, and nano\/micro devices for either diagnosis or therapy, or both, called theranostics. It also presents the latest advancements in healthcare materials and medical technology.\u003c\/p\u003e \u003cp\u003eThe senior researchers from global knowledge centers have written topics including:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eState-of-the-art of biomaterials for human health\u003c\/li\u003e \u003cli\u003eMicro- and nanoparticles and their application in biosensors\u003c\/li\u003e \u003cli\u003eThe role of immunoassays\u003c\/li\u003e \u003cli\u003eStimuli-responsive smart nanoparticles\u003c\/li\u003e \u003cli\u003eDiagnosis and treatment of cancer\u003c\/li\u003e \u003cli\u003eAdvanced materials for biomedical application and drug delivery\u003c\/li\u003e \u003cli\u003eNanoparticles for diagnosis and\/or treatment of Alzheimers disease\u003c\/li\u003e \u003cli\u003eHierarchical modelling of elastic behavior of human dental tissue\u003c\/li\u003e \u003cli\u003eBiodegradable porous hydrogels\u003c\/li\u003e \u003cli\u003eHydrogels in tissue engineering, drug delivery, and wound care\u003c\/li\u003e \u003cli\u003eModified natural zeolites\u003c\/li\u003e \u003cli\u003eSupramolecular hydrogels based on cyclodextrin poly(pseudo)rotaxane\u003c\/li\u003e \u003cli\u003ePolyhydroxyalkanoate-based biomaterials\u003c\/li\u003e \u003cli\u003eBiomimetic molecularly imprinted polymers\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003ePreface xvii\u003cbr\u003e \u003cbr\u003e \u003cb\u003e1\u003c\/b\u003e \u003cb\u003eStimuli-Responsive Smart Nanoparticles for Biomedical Application 1\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eArnab De, Sushil Mishra and Subho Mozumdar\u003c\/i\u003e\u003ci\u003e\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e1.1 A Brief Overview of Nanotechnology 2\u003cbr\u003e \u003cbr\u003e 1.2 Nanoparticulate Delivery Systems 3\u003cbr\u003e \u003cbr\u003e 1.3 Delivery Systems 4\u003cbr\u003e \u003cbr\u003e 1.4 Polymers for Nanoparticle Synthesis 11\u003cbr\u003e \u003cbr\u003e 1.5 Synthesis of Nanovehicles 15\u003cbr\u003e \u003cbr\u003e 1.6 Dispersion of Preformed Polymers 16\u003cbr\u003e \u003cbr\u003e 1.7 Emulsion Polymerization 20\u003cbr\u003e \u003cbr\u003e 1.8 Purification of Nanoparticle 22\u003cbr\u003e \u003cbr\u003e 1.9 Drying of Nanoparticles 24\u003cbr\u003e \u003cbr\u003e 1.10 Drug Loading 25\u003cbr\u003e \u003cbr\u003e 1.11 Drug Release 26\u003cbr\u003e \u003cbr\u003e 1.12 Conclusion 27\u003cbr\u003e \u003cbr\u003e References 27\u003cbr\u003e \u003cbr\u003e \u003cb\u003e2\u003c\/b\u003e \u003cb\u003eDiagnosis and Treatment of Cancer—Where We Are\u003c\/b\u003e \u003cb\u003eand Where We Have to Go! 35\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eR\u003c\/i\u003e\u003ci\u003ea\u003c\/i\u003e\u003ci\u003ejiv\u003c\/i\u003e \u003ci\u003eLochan Gaur and Richa Srivastava\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e2.1 Cancer Pathology 36\u003cbr\u003e \u003cbr\u003e 2.2 Cancer Diagnosis 37\u003cbr\u003e \u003cbr\u003e 2.3 Treatment 41\u003cbr\u003e \u003cbr\u003e Conclusion 42\u003cbr\u003e \u003cbr\u003e References 42\u003cbr\u003e \u003cbr\u003e \u003cb\u003e3\u003c\/b\u003e \u003cb\u003eAdvanced Materials for Biomedical Application and\u003c\/b\u003e \u003cb\u003eDrug Delivery 47\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eSalam\u003c\/i\u003e \u003ci\u003eJ.J.\u003c\/i\u003e \u003ci\u003eT\u003c\/i\u003e\u003ci\u003eitinchi\u003c\/i\u003e\u003ci\u003e,\u003c\/i\u003e \u003ci\u003eM\u003c\/i\u003e\u003ci\u003eayank\u003c\/i\u003e \u003ci\u003eP\u003c\/i\u003e\u003ci\u003e.\u003c\/i\u003e \u003ci\u003eSingh, Hanna S. Abbo and Ivan R. Green\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e3.1 Introduction 48\u003cbr\u003e \u003cbr\u003e 3.2 Anticancer Drug Entrapped Zeolite Structures as Drug Delivery Systems 48\u003cbr\u003e \u003cbr\u003e 3.3 Mesoporous Silica Nanoparticles and Multifunctional Magnetic Nanoparticles in Biomedical Applications 52\u003cbr\u003e \u003cbr\u003e 3.4 BioMOFs: Metal-Organic Frameworks for Biological and Medical Applications 64\u003cbr\u003e \u003cbr\u003e 3.5 Conclusions 75\u003cbr\u003e \u003cbr\u003e References 75\u003cbr\u003e \u003cbr\u003e \u003cb\u003e4\u003c\/b\u003e \u003cb\u003eNanoparticles for Diagnosis and\/or Treatment of\u003c\/b\u003e \u003cb\u003eAlzheimer’s Disease 85\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eS.G.\u003c\/i\u003e \u003ci\u003eAntimisiaris, S. Mourtas, E. Markoutsa, A. Skouras,\u003c\/i\u003e \u003ci\u003eand K. Papadia\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e4.1 Introduction 85\u003cbr\u003e \u003cbr\u003e 4.2 Nanoparticles 86\u003cbr\u003e \u003cbr\u003e 4.3 Physiological Factors Related with Brain-Located Pathologies: Focus on AD 96\u003cbr\u003e \u003cbr\u003e 4.4 Current Methodologies to Target AD-Related Pathologies 110\u003cbr\u003e \u003cbr\u003e 4.5 Nanoparticles for Diagnosis of AD 136\u003cbr\u003e \u003cbr\u003e 4.6 Nanoparticles for Therapy of AD 146\u003cbr\u003e \u003cbr\u003e 4.7 Summary of Current Progress and Future Challenges 160\u003cbr\u003e \u003cbr\u003e Acknowledgments 161\u003cbr\u003e \u003cbr\u003e References 161\u003cbr\u003e \u003cbr\u003e \u003cb\u003e5 \u003c\/b\u003e \u003cb\u003eNovel Biomaterials for Human Health: Hemocompatible Polymeric Micro-and Nanoparticles and Their\u003c\/b\u003e \u003cb\u003eApplication in Biosensor 179\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eC\u003c\/i\u003e\u003ci\u003ehong\u003c\/i\u003e \u003ci\u003eSun\u003c\/i\u003e\u003ci\u003e, Xiaobo Wang, Chun Mao and Jian Shen\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e5.1 Introduction 179\u003c\/p\u003e \u003cp\u003e5.2 Design and Preparation of Hemocompatible Polymeric Micro- and Nanoparticles 181\u003c\/p\u003e \u003cp\u003e5.3 The Biosafety and Hemocompatibility Evaluation System for Polymeric Micro- and Nanoparticles 183\u003c\/p\u003e \u003cp\u003e5.4 Construction of Biosensor for Direct Detection in Whole Blood 188\u003cbr\u003e \u003cbr\u003e 5.5 Conclusion and Prospect 194\u003cbr\u003e \u003cbr\u003e References 195\u003cbr\u003e \u003cbr\u003e \u003cb\u003e6\u003c\/b\u003e \u003cb\u003eThe Contribution of Smart Materials and Advanced Clinical Diagnostic Micro-Devices on the Progress and Improvement\u003c\/b\u003e \u003cb\u003eof Human Health Care 199\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eT\u003c\/i\u003e\u003ci\u003eeles\u003c\/i\u003e\u003ci\u003e,\u003c\/i\u003e \u003ci\u003eF.R.R. and Fonseca, L.P.\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e6.1 Introduction 200\u003cbr\u003e \u003cbr\u003e 6.2 Physiological Biomarkers as Targets in Clinical Diagnostic Bioassays 202\u003c\/p\u003e \u003cp\u003e6.3 Biosensors 205\u003c\/p\u003e \u003cp\u003e6.4 Advanced Materials and Nanostructures for Health Care Applications 217\u003c\/p\u003e \u003cp\u003e6.5 Applications of Micro-Devices to Some Important Clinical Pathologies 223\u003cbr\u003e \u003cbr\u003e 6.6 Conclusions and Future Prospects 227\u003cbr\u003e \u003cbr\u003e Acknowledgment 227\u003cbr\u003e \u003cbr\u003e References 228\u003cbr\u003e \u003cbr\u003e \u003cb\u003e7\u003c\/b\u003e \u003cb\u003eHierarchical Modeling of Elastic Behavior of Human Dental\u003c\/b\u003e \u003cb\u003eTissue Based on Synchrotron Diffraction Characterization 233\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eTan\u003c\/i\u003e\u003ci\u003eSui and Alexander M. Korsunsky\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e7.1  Introduction 233\u003cbr\u003e \u003cbr\u003e 7.2 Experimental Techniques 236\u003cbr\u003e \u003cbr\u003e 7.3 Model Formulation 238\u003cbr\u003e \u003cbr\u003e 7.4 Experimental Results and Model Validation 245\u003cbr\u003e \u003cbr\u003e 7.5 Discussion 251\u003cbr\u003e \u003cbr\u003e 7.6 Conclusions 255\u003cbr\u003e \u003cbr\u003e Acknowledgments 256\u003cbr\u003e \u003cbr\u003e Appendix 256\u003cbr\u003e \u003cbr\u003e References 260\u003cbr\u003e \u003cbr\u003e \u003cb\u003e8\u003c\/b\u003e \u003cb\u003eBiodegradable Porous Hydrogels 263\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMartin Pradny, Miroslav Vetrik, Martin Hruby\u003c\/i\u003e \u003ci\u003eand Jiri Michalek\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e8.1 Introduction 263\u003cbr\u003e \u003cbr\u003e 8.2 Methods of Preparation of Porous Hydrogels 265\u003cbr\u003e \u003cbr\u003e 8.3 Hydrogels Crosslinked With Degradable Crosslinkers 271\u003cbr\u003e \u003cbr\u003e 8.4 Hydrogels Degradable in the Main Chain 276\u003cbr\u003e \u003cbr\u003e 8.5 Conclusions 281\u003cbr\u003e \u003cbr\u003e Acknowledgments 281\u003cbr\u003e \u003cbr\u003e References 283\u003cbr\u003e \u003cbr\u003e \u003cb\u003e9\u003c\/b\u003e \u003cb\u003eHydrogels: Properties, Preparation, Characterization and Biomedical Applications in Tissue Engineering, Drug Delivery\u003c\/b\u003e \u003cb\u003eand Wound Care 289\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMohammad Sirousazar, Mehrdad Forough, Khalil Farhadi,\u003c\/i\u003e \u003ci\u003eY\u003c\/i\u003e\u003ci\u003easama\u003c\/i\u003e\u003ci\u003en\u003c\/i\u003e \u003ci\u003eShaabani and Rahim Molaei\u003cbr\u003e \u003cbr\u003e \u003c\/i\u003e9.1 Introduction 289\u003cbr\u003e \u003cbr\u003e 9.2 Types of Hydrogels 290\u003cbr\u003e \u003cbr\u003e 9.3 Properties of Hydrogels 295\u003cbr\u003e \u003cbr\u003e 9.4 Preparation Methods of Hydrogels 299\u003cbr\u003e \u003cbr\u003e 9.5 Characterization of Hydrogels 305\u003cbr\u003e \u003cbr\u003e 9.6 Biomedical Applications of Hydrogels 308\u003cbr\u003e \u003cbr\u003e 9.7 Hydrogels for Wound Management 319\u003cbr\u003e \u003cbr\u003e 9.8 Recent Developments on Hydrogels 337\u003cbr\u003e \u003cbr\u003e 9.9 Conclusions 340\u003cbr\u003e \u003cbr\u003e References 341\u003cbr\u003e \u003cbr\u003e \u003cb\u003e10\u003c\/b\u003e \u003cb\u003eModified Natural Zeolites—Functional Characterization\u003c\/b\u003e \u003cb\u003eand Biomedical Application 353\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJ\u003c\/i\u003e\u003ci\u003ee\u003c\/i\u003e\u003ci\u003ela\u003c\/i\u003e \u003ci\u003eMili\u003c\/i\u003eæ, \u003ci\u003eAleksandra Dakovi\u003c\/i\u003eæ, Danina Krajišnik \u003ci\u003eand George E. Rottinghaus\u003c\/i\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003cb\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003c\/b\u003e10.1 Introduction 354\u003cbr\u003e \u003cbr\u003e 10.2 Surfactant Modified Zeolites (SMZs) 359\u003cbr\u003e \u003cbr\u003e 10.3 Minerals as Pharmaceutical Excipients 366\u003cbr\u003e \u003cbr\u003e 10.4 SMZs for Pharmaceutical Application 372\u003cbr\u003e \u003cbr\u003e 10.5 Conclusions 389\u003cbr\u003e \u003cbr\u003e Acknowledgement 390\u003cbr\u003e \u003cbr\u003e References 390\u003cbr\u003e \u003cbr\u003e \u003cb\u003e11\u003c\/b\u003e \u003cb\u003eSupramolecular Hydrogels Based on Cyclodextrin Poly(Pseudo)Rotaxane for New and Emerging\u003c\/b\u003e \u003cb\u003eBiomedical Applications 397\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJin\u003c\/i\u003e\u003ci\u003eHuang, Jing Hao, Debbie P. Anderson and\u003c\/i\u003e \u003ci\u003ePeter R. Chang\u003c\/i\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003cb\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003c\/b\u003e11.1 Introduction 398\u003cbr\u003e \u003cbr\u003e 11.2 Fabrication of Cyclodextrin Poly(pseudo)rotaxane-Based Hydrogels 400\u003cbr\u003e \u003cbr\u003e 11.3 Stimulus-Response Properties of Cyclodextrin Poly(pseudo)rotaxane Based Hydrogels 409\u003cbr\u003e \u003cbr\u003e 11.4 Nanocomposite Supramolecular Hydrogels 413\u003cbr\u003e \u003cbr\u003e 11.5 Biomedical Application of Cyclodextrin Poly(pseudo)rotaxane-Based Hydrogels 420\u003cbr\u003e \u003cbr\u003e 11.6 Conclusions and Prospects 425\u003cbr\u003e \u003cbr\u003e References 425\u003cbr\u003e \u003cbr\u003e \u003cb\u003e12\u003c\/b\u003e \u003cb\u003ePolyhydroxyalkanoate-Based Biomaterials for Applications\u003c\/b\u003e\u003cb\u003ein Biomedical Engineering 431\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eChenghao Zhu and Qizhi Chen\u003c\/i\u003e\u003cbr\u003e \u003cb\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003c\/b\u003e12.1 Introduction\u003cbr\u003e \u003cbr\u003e 12.2 Synthesis of PHAs 433\u003cbr\u003e \u003cbr\u003e 12.3 Processing and its Influence on the Mechanical Properties of PHAs 435\u003cbr\u003e \u003cbr\u003e 12.4 Mechanical Properties of PHA Sheets\/Films 436\u003cbr\u003e \u003cbr\u003e 12.5 PHA-Based Polymer Blends 439\u003cbr\u003e \u003cbr\u003e 12.6 Summary 451\u003cbr\u003e \u003cbr\u003e References 451\u003cbr\u003e \u003cb\u003e\u003cbr\u003e 13\u003c\/b\u003e \u003cb\u003eBiomimetic Molecularly Imprinted Polymers as Smart\u003c\/b\u003e \u003cb\u003eMaterials and Future Perspective in Health Care 457\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMohammad Reza Ganjali, Farnoush Faridbod\u003c\/i\u003e \u003ci\u003eand Parviz Norouzi\u003c\/i\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003cb\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003c\/b\u003e13.1 Molecularly Imprinted Polymer Technology 458\u003cbr\u003e \u003cbr\u003e 13.2 Synthesis of MIPs 458\u003cbr\u003e \u003cbr\u003e 13.3 Application of MIPs 463\u003cbr\u003e \u003cbr\u003e 13.4 Biomimetic Molecules 464\u003cbr\u003e \u003cbr\u003e 13.5 MIPs as Receptors in Bio-Molecular Recognition 465\u003cbr\u003e \u003cbr\u003e 13.6 MIPs as Sensing Elements in Sensors\/Biosensors 466\u003cbr\u003e \u003cbr\u003e 13.7 MIPs as Drug Delivery Systems 467\u003cbr\u003e \u003cbr\u003e 13.8 MIPs as Sorbent Materials in Separation Science 475\u003cbr\u003e \u003cbr\u003e 13.9 Future Perspective of MIP Technologies 480\u003cbr\u003e \u003cbr\u003e 13.10 Conclusion 480\u003cbr\u003e \u003cbr\u003e References 480\u003cbr\u003e \u003cbr\u003e \u003cb\u003e14\u003c\/b\u003e \u003cb\u003eThe Role of Immunoassays in Urine Drug Screening 485\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eNiina\u003c\/i\u003e \u003ci\u003eJ.\u003c\/i\u003e \u003ci\u003eRonkainen and Stanley L. Okon\u003c\/i\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003cb\u003e\u003ci\u003e\u003cbr\u003e \u003c\/i\u003e\u003c\/b\u003e14.1 Introduction 486\u003cbr\u003e \u003cbr\u003e 14.2 Urine and Other Biological Specimens 489\u003cbr\u003e \u003cbr\u003e 14.3 Immunoassays 491\u003cbr\u003e \u003cbr\u003e 14.4 Drug Screening with Immunoassays 504\u003cbr\u003e \u003cbr\u003e 14.5 Immunoassay Specificity: False Negative and False Positive Test Results 507\u003cbr\u003e \u003cbr\u003e 14.6 Confirmatory Secondary Testing Using Chromatography Instruments 510\u003cbr\u003e \u003cbr\u003e Conclusion 513\u003cbr\u003e \u003cbr\u003e References\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Mechanical engineering \u0026amp; materials [\u003ca title=\"See our other books on Mechanical engineering \u0026amp; materials\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Mechanical%20engineering%20\u0026amp;%20materials%20%5BTG%5D%22\"\u003eTG\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley-Scrivener","offers":[{"title":"Brand New","offer_id":52421370151192,"sku":"9781118773598","price":131.59,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9781118773598.jpg?v=1784592808","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/advanced-healthcare-materials-hardback-9781118773598","provider":"Freshly Printed Books","version":"1.0","type":"link"}